Skip to main content
Apollo Hospitals Enterprises Ltd. logo

Apollo Hospitals Enterprises Ltd. — Investor Relations & Filings

Ticker · APOLLOHOSP ISIN · INE437A01024 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,911 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS APOLLOHOSP

About Apollo Hospitals Enterprises Ltd.

https://www.apollohospitals.com/

Apollo Hospitals Enterprises Ltd. is an integrated healthcare provider operating a vast network of multi-specialty hospitals, primary care facilities, and diagnostic centers. The organization offers specialized clinical services in fields such as cardiology, oncology, neurology, orthopedics, and multi-organ transplants. Its business model encompasses an extensive retail pharmacy chain and a digital health ecosystem, Apollo 24/7, providing teleconsultations and home-based care. The company leverages advanced medical infrastructure, including robotic surgery systems and proton therapy, to provide complex tertiary care. Serving both domestic and international patients, the company integrates preventive health screenings, emergency medical services, and clinical research. The focus remains on delivering comprehensive medical solutions through a vertically integrated model that spans from primary clinics to advanced quaternary care centers.

Recent filings

Filing Released Lang Actions
Record Date
Regulatory Filings Classification · 85% confidence The document is an intimation of the outcome of the Board Meeting under SEBI Listing Regulations, sent to Bombay Stock Exchange and National Stock Exchange. It includes audited standalone and consolidated results for the quarter and year ended March 31, 2026, dividend recommendation, AGM convening, director re-appointments, M&A transactions, and large corporate disclosures. It is a regulatory disclosure under listing obligations rather than the report itself (Annual Report or Interim Report), and does not neatly fit a more specific category. Therefore, it falls under Regulatory Filings (RNS).
2026-05-20 English
Dividend
Interim / Quarterly Report Classification · 85% confidence The document is an official SEBI (Listing Obligations and Disclosure Requirements) Regulation 30, 33, and 52 filing, containing the Board’s approval of the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 along with full financial statements and auditor’s reports. It also includes dividend recommendation, AGM notice, director reappointments, and transaction approvals, but the primary element is the full interim/quarterly (and year‐end) financial report with substantive data, not merely a high‐level earnings highlight or a simple announcement of publication. This aligns with the “Interim / Quarterly Report (IR)” definition — a comprehensive financial report for a period shorter than a full fiscal year, containing actual financial statements and analysis. FY 2026
2026-05-20 English
Outcome of Board Meeting
Regulatory Filings Classification · 87% confidence The document is a formal SEBI Listing Regulations disclosure of the Board Meeting outcome, filed with BSE & NSE. It includes audited financial results (standalone & consolidated), dividend proposals, AGM details, director re-appointments, corporate transactions, merger proposals, and borrowings disclosure – classic sections of a regulatory announcement under SEBI LODR. It is not a full Annual Report (10-K), nor merely an earnings highlights release (ER), nor a designated interim/quarterly report (IR) but rather a general compliance filing covering multiple items. Therefore this falls under general Regulatory Filings (RNS).
2026-05-20 English
as per annexure enclosed
Interim / Quarterly Report Classification · 85% confidence The document is an exchange filing under SEBI Listing Regulations disclosing the audited financial results for the quarter and year ended 31 March 2026 (including full P&L and balance sheet) along with audit reports, dividend recommendation, AGM notice, and various board approvals. It contains substantial financial statements and data (not merely a link or certification), consistent with a quarterly/interim results release rather than a brief earnings highlight or the full annual report. Therefore, it should be classified as an Interim / Quarterly Report (IR). FY 2026
2026-05-20 English
As per annexure enclosed
Regulatory Filings Classification · 82% confidence The document is a regulatory disclosure under SEBI Listing Regulations (Regulation 30), informing stock exchanges of a credit rating affirmation by ICRA for Apollo Hospitals’ bank facilities. It does not present substantive financial statements or results, nor is it a financing issuance, interest rate notice, or a standalone credit facility deal announcement. It is a required continuous disclosure under listing rules and does not fit other more specific categories. Therefore, it falls into the catch-all “Regulatory Filings” category.
2026-05-19 English
Credit Rating- New
Capital/Financing Update Classification · 95% confidence The document is a letter from ICRA Limited, a credit rating agency, addressed to the CFO of Apollo Hospitals Enterprise Limited. It communicates the credit rating assigned to specific financial instruments (term loans and unallocated limits) of the company. The letter includes rating actions, terms, and conditions, and a detailed annexure of bank limits rated. There are no financial statements, management discussion, or detailed financial performance data. The document is a credit rating update or rating action letter, which is an update on financing activities and capital structure rather than a full financial report or audit. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is about 5116 characters, which is sufficient for a detailed rating letter but not a full annual or interim report. Hence, the classification is CAP with high confidence.
2026-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.